To test whether AT2‑derived lipids are required for metastasis, the researchers selectively deleted Fasn in AT2 cells.

PREVENT risk estimation starts at age 30 and incorporates lifetime risk, enabling earlier identification of patients who warrant intensified lipid management and preventive therapies. LDL-C treatment ...

Engineers at the University of Pennsylvania have built a lipid nanoparticle that chemically fuses an IDO-pathway inhibitor with the very lipids that carry IL-12 mRNA into tumors, creating a single ...